The use of low molecular weight heparin for thromboprophylaxis in pregnancy
- 1 January 1994
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 101 (1), 69-71
- https://doi.org/10.1111/j.1471-0528.1994.tb13014.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Low molecular weight heparin in prevention of perioperative thrombosis.BMJ, 1992
- The Mode of Action of Low Molecular Weight Heparin Preparation (PK10169) and Two of its Major Components on Thrombin Generation in PlasmaThrombosis and Haemostasis, 1989
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administrationThrombosis Research, 1985
- Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasoundThrombosis Research, 1984
- A new low molecular weight heparin derivative. In vitro and in vivo studiesThrombosis Research, 1983
- Heparin assay in plasma: A comparison of five clotting methodsThrombosis Research, 1975